Reviva Pharmaceuticals Ownership | Who Owns Reviva Pharmaceuticals?


OverviewForecastChart

Reviva Pharmaceuticals Ownership Summary


Reviva Pharmaceuticals is owned by 41.39% institutional investors, 14.79% insiders, and 43.82% retail investors. Woodline partners lp is the largest institutional shareholder, holding 6.63% of RVPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.78% of its assets in Reviva Pharmaceuticals shares.

RVPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockReviva Pharmaceuticals41.39%14.79%43.82%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Woodline partners lp1.59M6.63%$2.04M
Millennium management1.24M5.17%$1.59M
Vanguard group1.03M4.27%$1.31M
Schonfeld strategic advisors1.01M4.22%$1.30M
Parkman healthcare partners504.60K2.10%$645.89K
Geode capital management236.12K0.98%$302.29K
Colony group161.00K0.67%$206.00K
Polar asset management partners154.80K0.64%$198.14K
Ubs group132.44K0.55%$169.52K
Emc capital management123.92K0.52%$140.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Parkman healthcare partners504.60K0.09%$645.89K
Emc capital management123.92K0.08%$140.00K
Woodline partners lp1.59M0.02%$2.04M
Nri wealth management lc12.38K0.01%$15.85K
Schonfeld strategic advisors1.01M0.01%$1.30M
Polar asset management partners154.80K0.00%$198.14K
Pale fire capital se25.00K0.00%$32.00K
Sound income strategies30.00K0.00%$38.40K
Millennium management1.24M0.00%$1.59M
Colony group161.00K0.00%$206.00K

Top Buyers

HolderShares% AssetsChange
Woodline partners lp1.59M0.02%537.78K
Millennium management1.24M0.00%386.90K
Schonfeld strategic advisors1.01M0.01%187.19K
Ubs group132.44K-124.34K
Two sigma investments, lp31.07K0.00%31.07K

Top Sellers

HolderShares% AssetsChange
Sabby management---237.00K
Jpmorgan chase---38.66K
Marshall wace, llp---34.87K
Jane street group---30.09K
Susquehanna group, llp35.60K--18.70K

New Positions

HolderShares% AssetsChangeValue
Sound income strategies30.00K0.00%30.00K$38.40K
Group one trading29.39K0.00%29.39K$37.62K
Activest wealth management1.00K0.00%1.00K$1.28K
Advisor group125.00-125.00$160.00

Sold Out

HolderChange
Qube research-50.00
Wells fargo & company/mn-175.00
Archer investment-500.00
Vontobel-14.00K
Jane street group-30.09K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024375.71%9,947,22745.22%415.10%15-25.00%980.00%
Jun 30, 2024356.06%6,849,68722.89%285.30%2025.00%5-16.67%
Mar 31, 202433-28.26%5,573,8375.84%234.83%16-42.86%6-14.29%
Dec 31, 20234615.00%5,266,25697.73%2115.55%2847.37%7-22.22%
Sep 30, 20234033.33%2,663,3851.20%118.17%19-9350.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv930.44K2.78%230.00K
Vanguard Institutional Extnd Mkt Idx Tr312.30K0.93%-
Fidelity Extended Market Index150.16K0.45%22.51K
iShares Micro-Cap ETF51.98K0.16%-
BlackRock Extended Equity Market K48.10K0.15%-20.00
Fidelity Total Market Index40.51K0.12%-
Fidelity Series Total Market Index34.76K0.10%6.21K
Northern Trust Extended Eq Market Idx34.12K0.10%-
NT Ext Equity Mkt Idx Fd - L34.12K0.10%-
NT Ext Equity Mkt Idx Fd - NL22.18K0.07%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 18, 2022Patel Purav-Buy$14.07K
Sep 30, 2022Narayan Prabhu Chief Financial OfficerBuy$83.00K
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$86.96
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$51.38
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$2.09M

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3--
2023 Q4--
2023 Q2--
2022 Q41-

RVPH Ownership FAQ


Who Owns Reviva Pharmaceuticals?

Reviva Pharmaceuticals shareholders are primarily institutional investors at 41.39%, followed by 14.79% insiders and 43.82% retail investors. The average institutional ownership in Reviva Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Reviva Pharmaceuticals falls below.

Who owns the most shares of Reviva Pharmaceuticals?

Reviva Pharmaceuticals’s largest shareholders are Woodline partners lp (1.59M shares, 6.63%), Millennium management (1.24M shares, 5.17%), and Vanguard group (1.03M shares, 4.27%). Together, they hold 16.06% of Reviva Pharmaceuticals’s total shares outstanding.

Does Blackrock own Reviva Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Reviva Pharmaceuticals.

Who is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Parkman healthcare partners is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.09% of its assets in 504.6K Reviva Pharmaceuticals shares, valued at 645.89K$.

Who is the top mutual fund holder of Reviva Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Reviva Pharmaceuticals shares, with 2.78% of its total shares outstanding invested in 930.44K Reviva Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools